Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05078229 · ClinicalTrials.gov registry record · NA
Evaluating Stress Management Among Allogeneic HCT Caregivers
A NA study of Stress and Burden, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Active
- Registry status
- NA
- Development phase
- 505
- Enrollment target
- 1
- Study location
NCT05078229: Active NA study of Stress and Burden, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT05078229 is a NA study of Stress and Burden that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 505 participants, below the 783-participant average among 152 other Stress trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05078229, a NA study of Stress and Burden, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 505 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to understand whether different stress management interventions impact stress among HCT cancer caregivers and patients.
Primary Outcome
Caregiver burden will be measured using the Zarit Burden Interview Short Form (ZBI). The ZBI is 12 items using a 5-point Likert scale assessing caregiver burden. Participants rate burden on a scale of 0 to 4, 0 indicating "rarely" an issue and 4 indicating "nearly always" The ZBI has been validated in populations of cancer caregivers and has demonstrated very good internal consistency and discriminative ability
Interventions
- BEHAVIORAL Healthy Living
- BEHAVIORAL FOCUS
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 505 participants |
| Start Date | 2021-09-16 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT05078229 still lists
NCT05078229 is an interventional study that assigns participants to a tested intervention. The registered 505 participants enrollment target is mid-sized for trials with a published cap, below the 783-participant average among 152 other Stress trials with a reported enrollment target (36% lower).
The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Healthy Living is the first listed.
NCT05078229 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05078229 about?
NCT05078229 is a clinical study titled "Evaluating Stress Management Among Allogeneic HCT Caregivers". The purpose of the study is to understand whether different stress management interventions impact stress among HCT cancer caregivers and patients.
What is the current status of trial NCT05078229?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 505 participants. The study started on 2021-09-16. Estimated completion is 2026-03-31.
What conditions does trial NCT05078229 study?
This clinical trial studies the following conditions: Stress, Burden.
What interventions are being tested in trial NCT05078229?
The interventions under investigation include: Healthy Living (BEHAVIORAL), FOCUS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05078229?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05078229 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05078229's enrollment target sits among peer trials
505 10th of 152 higher than 143 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05069428 · 506 participants · Phase 4
Delirium Reduction With Ramelteon
- NCT05797168 · 506 participants · Phase 1
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- NCT05846282 · 504 participants · NA
Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience
- NCT06072131 · 504 participants · Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI